DiaMedica Therapeutics Inc
NASDAQ:DMAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
AKR Corporindo Tbk PT
IDX:AKRA
|
ID |
|
ALK-Abello A/S
OTC:AKBLF
|
DK |
|
Intercede Group PLC
OTC:IRCDF
|
UK |
|
A
|
Arribatec Group ASA
OSE:ARR
|
NO |
Wall St Price Targets
DMAC Price Targets Summary
DiaMedica Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMAC's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.